HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought
In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th
AACI Told Medicare “Probably” Has Paid For Extra Patient Care Costs Of Research; Members Object To “Two Level System”
New RFAs on Retinoids & Carotenoids, Tobacco, NMR Research Resistance
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds
- Early-onset colorectal cancer is behaving like a new, biologically distinct disease, researchers note
One woman’s pregnancy shows how this distinction matters - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data in ACS guideline support greater use of noninvasive tests to ease system strain, save lives - A new diagnostic lens—and a lasting scientific legacy
- More than 50 million Americans remain unscreened for colon cancer
New guidelines offer another option









